Overall rank by patents
#25,176
Across all tracked assignees
USPTO PatentsView assignee record - 11 granted patents across 17 technology areas, active 2015–2017. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C08F (MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS).
The verdict
Solvay holds 11 US patents across 17 technology areas, rank #25,176 of 50,000 tracked assignees.
Solvay Solexis S.p.a. has been granted 11 US utility patents between 2015 and 2017, placing Solvay Solexis S.p.a. at rank #25,176 across all assignees tracked by PlainPatent. This portfolio spans 17 distinct Cooperative Patent Classification (CPC) subclasses, averaging 15.8 claims per patent with primary concentration in C08F (MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS). As a Foreign Corporation, Solvay Solexis S.p.a. is one of the more focused assignees in the PatentsView dataset. By volume, Solvay sits between Snipr Biome APS (11 patents, rank #25,172) and Spectrum Optix Inc. (11 patents, rank #25,180) - the closest US assignees by grant volume. The composite Innovation Score of 32.6/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 0 grants, compared with 11 in the 2015–2019 window, a -100% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Solvay Solexis S.p.a.'s 15.8 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 17 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Solvay Solexis S.p.a. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
SNIPR BIOME APS
11 patents
SOCIETE POUR LA CONCEPTION DES APPLICATIONS DES TECHNIQUES ELECTRONIQUES
11 patents
SOFICS BVBA
11 patents
SOLARIS OILFIELD SITE SERVICES OPERATING LLC
11 patents
SONDEX WIRELINE LIMITED
11 patents
SPECIALIZED DESANDERS INC.
11 patents
SPECLIPSE, INC.
11 patents
SPECTRUM OPTIX INC.
11 patents
SOLVAY SOLEXIS S.P.A.
11 patents
What this shows Solvay holds 11 patents at rank #25,176, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Solvay's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
33 Top 58% higher than 42% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 8 | 72.7% |
| 2016 | 2 | 18.2% |
| 2017 | 1 | 9.1% |
Top 15 of 17 technology areas
Overall rank by patents
#25,176
Across all tracked assignees
32.6 out of 100
How to use this portfolio
Solvay's 11 grants land it in the top 58% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.